Evaluating the short-term impact of a tobacco-free policy in an inpatient addiction treatment setting.


Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
12 2019
Historique:
received: 30 01 2019
revised: 20 09 2019
accepted: 27 09 2019
entrez: 24 11 2019
pubmed: 24 11 2019
medline: 1 9 2020
Statut: ppublish

Résumé

Tobacco use is highly prevalent within addiction treatment settings, despite the potential benefits that cessation may provide to patients' psychosocial functioning and overall sobriety. Moreover, tobacco cessation is often insufficiently addressed in addiction treatment programs, although evidence suggests that tobacco control policies, such as access to evidence-based treatment or tobacco-free policies, may be effective. The objective of our study was to evaluate the impact of the implementation of these two tobacco control policies in an inpatient addiction treatment centre. Using a 3-group quasi-experimental design, we examined how the implementation of the Ottawa Model for Smoking Cessation (OMSC) and a subsequent campus-wide tobacco ban influenced patients' overall smoking status, frequency, amount used per day, and quit attempts during treatment, compared to usual care. Participants (N = 397) responded to a comprehensive questionnaire upon admission and discharge from an addiction treatment program. We used generalized linear mixed modelling to measure changes over time while accounting for relevant sociodemographic covariates. Patients exposed to a more comprehensive tobacco control environment (i.e., the OMSC, plus complete tobacco ban) were over 80% less likely to report having used tobacco during treatment, compared to patients exposed to usual care (AOR = 0.17, 95% CI [0.05-0.63]). Receiving treatment in this setting also contributed to a 35% decrease in the average number of days patients used tobacco compared to usual care (AOR = 0.65, 95% CI [0.53-0.98]), and a 27% decrease in the average number of cigarettes used per day compared to usual care (AOR = 0.73, 95% CI [0.58-0.93]). Comprehensive tobacco control policy interventions within inpatient addiction treatment hospitals promote tobacco cessation. Such interventions should include a combination of evidence-based treatment for patients and environmental restrictions to discourage tobacco use. The results of our study suggest that, within inpatient addiction treatment settings, use of the OMSC in combination with a campus-wide tobacco ban may be more effective than usual care or the OMSC alone.

Identifiants

pubmed: 31757265
pii: S0740-5472(19)30045-5
doi: 10.1016/j.jsat.2019.09.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

50-59

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Isabella Romano (I)

School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada; Homewood Research Institute, Guelph, ON, Canada.

Mary Jean Costello (MJ)

School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada; Homewood Research Institute, Guelph, ON, Canada. Electronic address: JCostello@homewoodhealth.com.

Courtney Ropp (C)

Homewood Research Institute, Guelph, ON, Canada.

Yao Li (Y)

Homewood Research Institute, Guelph, ON, Canada.

Sarah Sousa (S)

School of Public Health and Health Systems, University of Waterloo, Waterloo, ON, Canada; Homewood Research Institute, Guelph, ON, Canada.

Dominique Bruce (D)

Homewood Health Centre, Guelph, ON, Canada.

Don Roth (D)

Homewood Health Centre, Guelph, ON, Canada.

James MacKillop (J)

Homewood Research Institute, Guelph, ON, Canada; Peter Boris Centre for Addiction Research, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada; Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada.

Brian Rush (B)

Homewood Research Institute, Guelph, ON, Canada; Centre for Addiction and Mental Health, Toronto, ON, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH